BGM Group Common Stock Net 2019-2024 | BGM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BGM Group common stock net from 2019 to 2024. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BGM Group common stock net from 2019 to 2024. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$160.6B
Vertex Pharmaceuticals (VRTX)	$126.2B
Bristol Myers Squibb (BMY)	$119.7B
Gilead Sciences (GILD)	$117.5B
Regeneron Pharmaceuticals (REGN)	$90.2B
CSL (CSLLY)	$90B
GSK (GSK)	$73.6B
Argenex SE (ARGX)	$35.5B
Alnylam Pharmaceuticals (ALNY)	$34.7B
BioNTech SE (BNTX)	$25.5B
Biogen (BIIB)	$24.5B
Illumina (ILMN)	$23.4B
BeiGene (BGNE)	$18.9B
Moderna (MRNA)	$16.7B
Incyte (INCY)	$15.5B
Genmab (GMAB)	$14.9B
BioMarin Pharmaceutical (BMRN)	$12.6B
Insmed (INSM)	$12.5B
Vaxcyte (PCVX)	$12.4B
Bio-Techne Corp (TECH)	$11.8B
Sarepta Therapeutics (SRPT)	$10.9B
Exelixis (EXEL)	$10.2B
Revolution Medicines (RVMD)	$10B
QIAGEN (QGEN)	$9.9B
Intra-Cellular Therapies (ITCI)	$9.4B
Bio-Rad Laboratories (BIO.B)	$9.4B
Exact Sciences (EXAS)	$9.3B
Roivant Sciences (ROIV)	$8.6B
Repligen (RGEN)	$8.3B
Ascendis Pharma (ASND)	$7.7B